Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000122130 | SCV002516078 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002262716 | SCV002544892 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | TET2: BP4, BS2 |
Labcorp Genetics |
RCV002262716 | SCV003252605 | likely benign | not provided | 2025-02-02 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000122130 | SCV000086345 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Prevention |
RCV003952616 | SCV004773027 | likely benign | TET2-related disorder | 2022-05-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |